135 related articles for article (PubMed ID: 38458322)
1. Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy.
Şimşek C; Wahlin S; Efe C
J Hepatol; 2024 Jul; 81(1):e41-e42. PubMed ID: 38458322
[No Abstract] [Full Text] [Related]
2. Autoimmune hepatitis: Azathioprine or mycophenolate mofetil for inducing remission?
Tiwari A; Khanikar D; Rathod SG
J Hepatol; 2024 Jul; 81(1):e38-e39. PubMed ID: 38403031
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Richardson PD; James PD; Ryder SD
J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
[TBL] [Abstract][Full Text] [Related]
4. Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".
Snijders RJALM; Stoelinga AEC; van Hoek B; Drenth JPH
J Hepatol; 2024 Jul; 81(1):e43-e44. PubMed ID: 38554845
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Fallatah HI; Akbar HO
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
[TBL] [Abstract][Full Text] [Related]
6. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
Brunt EM; Di Bisceglie AM
Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Autoimmune Hepatitis.
Goel A; Kwo P
Clin Liver Dis; 2024 Feb; 28(1):51-61. PubMed ID: 37945162
[TBL] [Abstract][Full Text] [Related]
8. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
Taheri M; Pourmand G; Mehrsai AR; Mansoori D
Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
[No Abstract] [Full Text] [Related]
9. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
Giannakopoulos G; Verbaan H; Friis-Liby IL; Sangfelt P; Nyhlin N; Almer S;
Dig Liver Dis; 2019 Feb; 51(2):253-257. PubMed ID: 30389427
[TBL] [Abstract][Full Text] [Related]
11. [Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].
Gaudy-Marqueste C
Ann Dermatol Venereol; 2007 Dec; 134(12):949-56. PubMed ID: 18166916
[No Abstract] [Full Text] [Related]
12. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM; Stoelinga AEC; Gevers TJG; Pape S; Biewenga M; Tushuizen ME; Verdonk RC; de Jonge HJM; Vrolijk JM; Bakker SF; Vanwolleghem T; de Boer YS; Baven Pronk MAMC; Beuers U; van der Meer AJ; Gerven NMFV; Sijtsma MGM; van Eijck BC; van IJzendoorn MC; van Herwaarden M; van den Brand FF; Korkmaz KS; van den Berg AP; Guichelaar MMJ; Levens AD; van Hoek B; Drenth JPH;
J Hepatol; 2024 Apr; 80(4):576-585. PubMed ID: 38101756
[TBL] [Abstract][Full Text] [Related]
13. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.
Santiago P; Schwartz I; Tamariz L; Levy C
Aliment Pharmacol Ther; 2019 Apr; 49(7):830-839. PubMed ID: 30761563
[TBL] [Abstract][Full Text] [Related]
15. The use of immunosuppression in autoimmune hepatitis: A current literature review.
Cropley A; Weltman M
Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
Czaja AJ
J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
[No Abstract] [Full Text] [Related]
17. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
[TBL] [Abstract][Full Text] [Related]
18. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
Czaja AJ; Carpenter HA
J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
[TBL] [Abstract][Full Text] [Related]
19. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
Chenhsu RY; Wu YM; Min DI; Zimmerman MB
Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
[No Abstract] [Full Text] [Related]
20. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
